Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhu rectum gel (银胡直肠凝胶) is a Traditional Chinese Medicine (TCM) botanical product developed by the Shanghai Medical Innovation Traditional Chinese Medicine Research and Development Center. It is formulated as a rectal gel specifically intended for the treatment of acute exacerbations of bronchial asthma in pediatric patients, particularly those presenting with the 'Heat-Asthma' (热哮证) syndrome. The rectal route of administration is chosen to facilitate ease of use and potentially rapid absorption in children. The product is currently undergoing Phase 2 clinical evaluation in China (e.g., trial CTR20243032) to assess its safety and preliminary therapeutic efficacy compared to a low-dose control group.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinhu rectum gel.